RYAH Group Inc. (CSE: RYAH) Reveals Attendance at the Wall Street Reporter’s Next Super Stock Livestream Conference

• RYAH Group is a digital healthcare analytics and technology company focused on developing tools that provide patients and doctors with the ability to accurately manage the intake in plant-based treatment
• The company recently revealed its participation at the Wall Street Reporter’s ‘Next Super Stock’ livestream conference held on September 23, 2021

RYAH Group (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company specializes in developing volume-control IoT devices to provide accurate volume control and management for various medical purposes.

RYAH Group’s management recently revealed their attendance at the Wall Street Reporter’s “Next Super Stock” livestream conference, held on September 23, 2021  (https://ibn.fm/QtOfB). 

Wall Street Reporter’s Next Super Stock conference (https://ibn.fm/f5977) features select companies with major near-term catalysts in place to drive transformational growth (and stock appreciation) in the months ahead. 

Due to the ‘Next Super Stock’ conference’s track record showcasing companies which have enjoyed exponential increases in the weeks following the conference, hundreds of institutional investors habitually attend the meeting in anticipation of discovering the next big breakthrough. 

RYAH Group’s current product portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component, and the mobile application. The product line currently includes a Smart Dry-Herb Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage, and a Smart Liquid Dispensing Pen in the prototype stage.

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and pre-sets for temperatures and volumes. All of these features are customizable to individual needs and doctor recommendations. 

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and heating element are completely IoT and controlled by RYAH’s proprietary smartphone applications, allowing on-demand scheduling and ‘boosting’ medicine release.

RYAH’s Smart Liquid Dispensing Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect,’ enabling customized, wide-spectrum recommendation opportunities by licensed clinicians.

RYAH Group’s product suite of precision intake and volume management devices provides patients and medical practitioners with a practical toolkit to abide by volume control guidelines safely and accurately. In addition, detailed analytics provided by these RYAH devices help determine which intake volumes are working and what needs adjusting, along with accurately depicting a patient’s progress in their treatment.

For more information, visit the company’s website at www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.